So far, researchers have discovered that oxidative inflammation increases the frequency of relapses in patients with relapse-remitting multiple sclerosis (RRMS) and that oxidative stress can be stopped by activating the Nrf2 pathway — which is a protein found in all of the body’s cells. The Nrf2 pathway regulates defensive antioxidants and can make remyelination occur and help to reverse the effects of multiple sclerosis. Read more about this story here.
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.